MedPath

Evaluation of an Open-Label Placebo Appetite suppressant - An eye-tracking study

Not Applicable
Completed
Conditions
healthy participants
Registration Number
DRKS00031301
Lead Sponsor
niversität Graz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
53
Inclusion Criteria

Normal or corrected-to-normal vision at 1m distance

Exclusion Criteria

Medication that may affect eating beavior/appetite.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Immediately after ingestion of the placebo (omitted in the control condition), eye movements are recorded while looking at food images, and appetite is recorded every 20 trials (6-point Likert scale). Subsequently, the specific appetite for a subset of the presented foods is elicited. Finally, a (sweet) taste sample is rated (Intensität und Präferenz).
Secondary Outcome Measures
NameTimeMethod
Exploratory analysis of associations between efficacy expectations of participants and actual reductions in appetite for/attention to high-calorie (high-sugar) foods(illustrations).<br>The German language version of the Eating Disorder Examination Questionnaire is used for the sample description.
© Copyright 2025. All Rights Reserved by MedPath